Tag:
Latuda
Latest Headlines
Latest Headlines
Sunovion lobs Latuda into crowded atypicals market
Sunovion Pharmaceuticals' new antipsychotic drug has hit drugstores, aiming to capture a share of the already crowded market. It's a branded drug in a class that now includes one leading
Two drugs, two price-setting tales
As governments worldwide slash prices on prescription meds, drugmakers in the U.S. are raising them. Cancer specialist Celgene ( $CELG ) has raised the price of its Revlimid pill for multiple myeloma
